Global Information
회사소개 | 문의 | 비교리스트

세계의 의약품 중간체 시장 : 종류별(GMP, 비GMP), 용도별(항생물질, 해열진통제, 비타민, 기타), 유통 채널별(도매업체, 직판), 지역별 시장 규모 조사와 예측(2021-2027년)

Global Pharmaceutical intermediates Market Size study, by Type (GMP, Non-GMP) by Application (Antibiotics, Antipyretic Analgesics, Vitamins, Others), by Distribution Channel (Distributor, Direct sales) and Regional Forecasts 2021-2027

리서치사 Bizwit Research & Consulting LLP
발행일 2021년 07월 상품코드 1019152
페이지 정보 영문 배송안내 2-3일 (영업일 기준)
가격
US $ 4,950 ₩ 7,031,000 Unprintable PDF (Single User License)
US $ 6,250 ₩ 8,878,000 Printable PDF (Enterprise License)


세계의 의약품 중간체 시장 : 종류별(GMP, 비GMP), 용도별(항생물질, 해열진통제, 비타민, 기타), 유통 채널별(도매업체, 직판), 지역별 시장 규모 조사와 예측(2021-2027년) Global Pharmaceutical intermediates Market Size study, by Type (GMP, Non-GMP) by Application (Antibiotics, Antipyretic Analgesics, Vitamins, Others), by Distribution Channel (Distributor, Direct sales) and Regional Forecasts 2021-2027
발행일 : 2021년 07월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 의약품 중간체 시장 규모는 2021-2027년의 예측기간 중 건전한 성장률로 성장할 것으로 예상됩니다.

의약품 중간체는 벌크 의약품 제조 원료로서 사용되는 의약품입니다. 중간체는 후에 최종 제품이 되는 반제품으로서 정의할 수 있습니다.

의약품 중간체 시장은 만성질환 증례 증가, CVD 증례에서 의약품 기반 의약품 수요 증가 및 감염증 증례 증가에 의해 견인되고 있습니다. 또한 세계보건기구(WHO)에 의하면 60세 이상의 인구는 2050년까지 약 20억명이 되고, 다양한 만성질환을 일으키기 때문에 시장은 확대될 것으로 예상됩니다. 예를 들어 개정된 전국 결핵 대책 프로그램 보고서에 의하면 2018년에는 인도에서 결핵에 의해 약 44만명의 환자가 사망했습니다. 이것은 세계의 결핵에 의한 총사망자수 150만명의 29%에 상당합니다. 따라서 만성질환 및 감염증의 이러한 높은 유병률은 약물 수요를 증가시키고 있으며, 최종적으로는 의약품 중간체의 필요성을 나타내고 있습니다.

그러나 막대한 중소 제조업체에 의한 불균일한 가격과 엄격한 규제는 2021-2027년의 예측기간 중 시장 성장을 저해할 가능성이 있습니다.

세계의 의약품 중간체(Pharmaceutical intermediates) 시장을 조사했으며, 시장 개요, 시장 성장 촉진요인 및 저해요인 분석, 시장 기회, 종류·용도·유통 채널·지역별 시장 규모 추정과 예측, 경쟁 상황, 주요 기업 개요 등 체계적인 정보를 제공합니다.

목차

제1장 주요 요약

제2장 시장 정의와 범위

제3장 시장 역학

  • 시장의 영향 분석(2019-2027년)

제4장 업계 분석

  • Porter's 5 Force 모델
  • PEST 분석
  • 투자 채용 모델
  • 애널리스트의 추천사항과 결론

제5장 종류별

  • 시장 현황
  • 실적 : 잠재적 분석
  • 시장 규모 예측 : 2018-2027년(10억 달러 단위)
  • 하위 부문 분석
    • GMP
    • 비GMP

제6장 용도별

  • 시장 현황
  • 실적 : 잠재적 분석
  • 시장 규모 예측 : 2018-2027년(10억 달러 단위)
  • 하위 부문 분석
    • 항생물질
    • 해열진통제
    • 비타민
    • 기타

제7장 유통 채널별

  • 시장 현황
  • 실적 : 잠재적 분석
  • 시장 규모 예측 : 2018-2027년(10억 달러 단위)
  • 하위 부문 분석
    • 도매업체
    • 직판

제8장 지역 분석

  • 지역 시장 현황
  • 북미
    • 미국
    • 캐나다
  • 유럽의 현황
    • 영국
    • 독일
    • 프랑스
    • 스페인
    • 이탈리아
    • 기타 유럽
  • 아시아태평양의 현황
    • 중국
    • 인도
    • 일본
    • 호주
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카의 현황
    • 브라질
    • 멕시코
  • 기타 지역

제9장 경쟁 정보

  • 주요 시장 전략
  • 기업 개요
    • Chiracon GmbH
    • BASF SE
    • Lonza Group
    • Evonik Industries AG
    • Cambrex Corporation
    • DSM
    • Aceto
    • Albemarle Corporation
    • Vertellus
    • Chemcon Speciality Chemicals Ltd.

제10장 조사 과정

KSM 21.08.02

LIST OF TABLES

  • TABLE 2. Global Pharmaceutical intermediates Market , report scope
  • TABLE 3. Global Pharmaceutical intermediates Market estimates & forecasts by region 2018-2027 (USD Billion)
  • TABLE 4. Global Pharmaceutical intermediates Market estimates & forecasts by Type 2018-2027 (USD Billion)
  • TABLE 5. Global Pharmaceutical intermediates Market estimates & forecasts by Application 2018-2027 (USD Billion)
  • TABLE 6. Global Pharmaceutical intermediates Market estimates & forecasts by Distribution Channel 2018-2027 (USD Billion)
  • TABLE 7. Global Pharmaceutical intermediates Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 8. Global Pharmaceutical intermediates Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 9. Global Pharmaceutical intermediates Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 10. Global Pharmaceutical intermediates Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 11. Global Pharmaceutical intermediates Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 12. Global Pharmaceutical intermediates Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 13. Global Pharmaceutical intermediates Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 14. Global Pharmaceutical intermediates Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 15. Global Pharmaceutical intermediates Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 16. Global Pharmaceutical intermediates Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 17. Global Pharmaceutical intermediates Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 18. Global Pharmaceutical intermediates Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 19. Global Pharmaceutical intermediates Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 20. Global Pharmaceutical intermediates Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 21. Global Pharmaceutical intermediates Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 22. Global Pharmaceutical intermediates Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 23. U.S. Pharmaceutical intermediates Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 24. U.S. Pharmaceutical intermediates Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 25. U.S. Pharmaceutical intermediates Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 26. Canada Pharmaceutical intermediates Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 27. Canada Pharmaceutical intermediates Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 28. Canada Pharmaceutical intermediates Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 29. UK Pharmaceutical intermediates Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 30. UK Pharmaceutical intermediates Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 31. UK Pharmaceutical intermediates Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 32. Germany Pharmaceutical intermediates Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 33. Germany Pharmaceutical intermediates Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 34. Germany Pharmaceutical intermediates Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 35. France Pharmaceutical intermediates Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 36. France Pharmaceutical intermediates Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 37. France Pharmaceutical intermediates Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 38. Spain Pharmaceutical intermediates Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 39. Spain Pharmaceutical intermediates Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 40. Spain Pharmaceutical intermediates Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 41. Italy Pharmaceutical intermediates Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 42. Italy Pharmaceutical intermediates Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 43. Italy Pharmaceutical intermediates Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 44. ROE Pharmaceutical intermediates Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 45. ROE Pharmaceutical intermediates Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 46. ROE Pharmaceutical intermediates Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 47. China Pharmaceutical intermediates Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 48. China Pharmaceutical intermediates Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 49. China Pharmaceutical intermediates Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 50. India Pharmaceutical intermediates Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 51. India Pharmaceutical intermediates Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 52. India Pharmaceutical intermediates Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 53. Japan Pharmaceutical intermediates Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 54. Japan Pharmaceutical intermediates Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 55. Japan Pharmaceutical intermediates Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 56. Australia Pharmaceutical intermediates Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 57. Australia Pharmaceutical intermediates Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 58. Australia Pharmaceutical intermediates Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 59. South Korea Pharmaceutical intermediates Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 60. South Korea Pharmaceutical intermediates Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 61. South Korea Pharmaceutical intermediates Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 62. ROPAC Pharmaceutical intermediates Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 63. ROPAC Pharmaceutical intermediates Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 64. ROPAC Pharmaceutical intermediates Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 65. Brazil Pharmaceutical intermediates Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 66. Brazil Pharmaceutical intermediates Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 67. Brazil Pharmaceutical intermediates Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 68. Mexico Pharmaceutical intermediates Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 69. Mexico Pharmaceutical intermediates Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 70. Mexico Pharmaceutical intermediates Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 71. ROLA Pharmaceutical intermediates Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 72. ROLA Pharmaceutical intermediates Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 73. ROLA Pharmaceutical intermediates Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 74. ROW Pharmaceutical intermediates Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 75. ROW Pharmaceutical intermediates Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 76. ROW Pharmaceutical intermediates Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 77. List of secondary sources used in the study of global Pharmaceutical intermediates Market .
  • TABLE 78. List of primary sources used in the study of global Pharmaceutical intermediates Market .
  • TABLE 79. Years considered for the study.
  • TABLE 80. Exchange rates considered.

LIST OF FIGURES

  • FIG 1. Global Pharmaceutical intermediates Market , research methodology
  • FIG 2. Global Pharmaceutical intermediates Market , market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Pharmaceutical intermediates Market , key trends 2020
  • FIG 5. Global Pharmaceutical intermediates Market , growth prospects 2021-2027
  • FIG 6. Global Pharmaceutical intermediates Market , porters 5 force model
  • FIG 7. Global Pharmaceutical intermediates Market , pest analysis
  • FIG 8. Global Pharmaceutical intermediates Market , value chain analysis
  • FIG 9. Global Pharmaceutical intermediates Market by segment, 2018 & 2027 (USD Billion)
  • FIG 10. Global Pharmaceutical intermediates Market by segment, 2018 & 2027 (USD Billion)
  • FIG 11. Global Pharmaceutical intermediates Market by segment, 2018 & 2027 (USD Billion)
  • FIG 12. Global Pharmaceutical intermediates Market by segment, 2018 & 2027 (USD Billion)
  • FIG 13. Global Pharmaceutical intermediates Market by segment, 2018 & 2027 (USD Billion)
  • FIG 14. Global Pharmaceutical intermediates Market by segment, 2018 & 2027 (USD Billion)
  • FIG 15. Global Pharmaceutical intermediates Market by segment, 2018 & 2027 (USD Billion)
  • FIG 16. Global Pharmaceutical intermediates Market by segment, 2018 & 2027 (USD Billion)
  • FIG 17. Global Pharmaceutical intermediates Market , regional snapshot 2018 & 2027
  • FIG 18. North America Pharmaceutical intermediates Market 2018 & 2027 (USD Billion)
  • FIG 19. Europe Pharmaceutical intermediates Market 2018 & 2027 (USD Billion)
  • FIG 20. Asia-Pacific Pharmaceutical intermediates Market 2018 & 2027 (USD Billion)
  • FIG 21. Latin America Pharmaceutical intermediates Market 2018 & 2027 (USD Billion)
  • FIG 22. Global Pharmaceutical intermediates Market , company market share analysis (2020)

Global Pharmaceutical intermediates Market is valued approximately at USD XX billion in 2020 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2021-2027. Pharmaceutical intermediates are drugs used as raw materials in the production of bulk drugs. Intermediates can be defined as semi-finished products that are later made into the final products. The Pharmaceutical intermediates market is being driven by increasing cases of chronic diseases, growing demand for pharmaceutical-based medicines in CVD cases, and increased cases of infectious diseases. Moreover, according to World health organization (WHO), the population ageing above 60 years will be around 2 billion by 2050, which will give rise to various chronic diseases therefore the market is expected to boost. For instance, according to revised National Tuberculosis Control Program Report, in 2018, around 4.4 lakh patients died due to tuberculosis in India, that is 29% of the total 1.5 million deaths caused by the disease across the world. Thus, such high prevalence of chronic diseases and infectious diseases is increasing the demand for drugs, eventually showcasing the need of pharmaceutical intermediates. However, uneven prices and strict regulation due to enormous small and medium class manufacturers may impede market growth over the forecast period of 2021-2027.

The regional analysis of the pharmaceutical intermediates Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. Asia Pacific has emerged as a significant region across the world in terms of market share due to growing population in the region. Whereas North America is also anticipated to exhibit the highest CAGR over the forecast period 2021-2027, due to the increasing cases of CVD and chronic diseases in the region

Major market player included in this report are:

Chiracon GmbH

BASF SE

Lonza Group

Evonik Industries AG

Cambrex Corporation

DSM

Aceto

Albemarle Corporation

Vertellus

Chemcon Speciality Chemicals Ltd.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

GMP

Non-GMP

By Application:

Antibiotics

Antipyretic Analgesics

Vitamins

Others

By Distribution Channel:

Distributor

Direct Sales

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019

Base year - 2020

Forecast period - 2021 to 2027.

Target Audience of the Pharmaceutical intermediates (PSF) Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
    • 1.2.1. Pharmaceutical intermediates Market , by Region, 2019-2027 (USD Billion)
    • 1.2.2. Pharmaceutical intermediates Market , by Type, 2019-2027 (USD Billion)
    • 1.2.3. Pharmaceutical intermediates Market , by Application , 2019-2027 (USD Billion)
    • 1.2.4. Pharmaceutical intermediates Market , by Distribution Channel, 2019-2027 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Pharmaceutical intermediates Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Pharmaceutical intermediates Market Dynamics

  • 3.1. Pharmaceutical intermediates Market Impact Analysis (2019-2027)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing prevalence of chronic diseases
      • 3.1.1.2. Growing R&D initiatives and activities in the pharmaceutical industry.
    • 3.1.2. Market Restraint
      • 3.1.2.1. Stringent rules and unstable pricing.
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Launch of innovative pharmaceutical intermediates

Chapter 4. Global Pharmaceutical intermediates Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Pharmaceutical intermediates Market , by Type

  • 5.1. Market Snapshot
  • 5.2. Global Pharmaceutical intermediates Market by Type, Performance - Potential Analysis
  • 5.3. Global Pharmaceutical intermediates Market Estimates & Forecasts by Type 2018-2027 (USD Billion)
  • 5.4. Pharmaceutical intermediates Market , Sub Segment Analysis
    • 5.4.1. GMP
    • 5.4.2. Non-GMP

Chapter 6. Global Pharmaceutical intermediates Market , by Application

a. Market Snapshot

  • 6.1. Global Pharmaceutical intermediates Market by Application, Performance - Potential Analysis
  • 6.2. Global Pharmaceutical intermediates Market Estimates & Forecasts by Application 2018-2027 (USD Billion)
  • 6.3. Pharmaceutical intermediates Market , Sub Segment Analysis
    • 6.3.1. Antibiotics
    • 6.3.2. Antipyretic Analgesics
    • 6.3.3. Vitamins
    • 6.3.4. Others

Chapter 7. Global Pharmaceutical intermediates Market , by Distribution Channel

b. Market Snapshot

  • 7.1. Global Pharmaceutical intermediates Market by Distribution Channel, Performance - Potential Analysis
  • 7.2. Global Pharmaceutical intermediates Market Estimates & Forecasts by Distribution Channel 2018-2027 (USD Billion)
  • 7.3. Pharmaceutical intermediates Market , Sub Segment Analysis
    • 7.3.1. Distributor
    • 7.3.2. Direct Sales

Chapter 8. Global Pharmaceutical intermediates Market , Regional Analysis

  • 8.1. Pharmaceutical intermediates Market , Regional Market Snapshot
  • 8.2. North America Pharmaceutical intermediates Market
    • 8.2.1. U.S. Pharmaceutical intermediates Market
      • 8.2.1.1. Type breakdown estimates & forecasts, 2018-2027
      • 8.2.1.2. Application breakdown estimates & forecasts, 2018-2027
      • 8.2.1.3. Distribution Channel breakdown estimates & forecasts, 2018-2027
    • 8.2.2. Canada Pharmaceutical intermediates Market
  • 8.3. Europe Pharmaceutical intermediates Market Snapshot
    • 8.3.1. U.K. Pharmaceutical intermediates Market
    • 8.3.2. Germany Pharmaceutical intermediates Market
    • 8.3.3. France Pharmaceutical intermediates Market
    • 8.3.4. Spain Pharmaceutical intermediates Market
    • 8.3.5. Italy Pharmaceutical intermediates Market
    • 8.3.6. Rest of Europe Pharmaceutical intermediates Market
  • 8.4. Asia-Pacific Pharmaceutical intermediates Market Snapshot
    • 8.4.1. China Pharmaceutical intermediates Market
    • 8.4.2. India Pharmaceutical intermediates Market
    • 8.4.3. Japan Pharmaceutical intermediates Market
    • 8.4.4. Australia Pharmaceutical intermediates Market
    • 8.4.5. South Korea Pharmaceutical intermediates Market
    • 8.4.6. Rest of Asia Pacific Pharmaceutical intermediates Market
  • 8.5. Latin America Pharmaceutical intermediates Market Snapshot
    • 8.5.1. Brazil Pharmaceutical intermediates Market
    • 8.5.2. Mexico Pharmaceutical intermediates Market
  • 8.6. Rest of The World Pharmaceutical intermediates Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Chiracon GmbH
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. BASF SE
    • 9.2.3. Lonza Group
    • 9.2.4. Evonik Industries AG
    • 9.2.5. Cambrex Corporation
    • 9.2.6. DSM
    • 9.2.7. Aceto
    • 9.2.8. Albemarle Corporation
    • 9.2.9. Vertellus
    • 9.2.10. Chemcon Speciality Chemicals Ltd.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption
Back to Top
전화 문의
F A Q